ADPT

Adaptive Biotechnologies Corporation

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$14.81

Market Cap

$2.28B

Beta

2.30

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+54.77%

EPS Growth (YoY)+63.17%

Revenue CAGR 3Y+14.34%

P/E Ratio0.0

PEG Ratio—

FCF Yield-2.15%

Debt / Equity1.28

Interest Coverage-4.8x

No credit card required

Already have an account? Sign in to view the full analysis for ADPT.